Manuel Portero Otin
Grau: Doctor/a
973 702 408
manuel.portero(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/B-7122-2009
Publicacions
-
Serrano JCE; Baena-Fustegueras, JA; Martin-Gari, M; Rassendren, H; Cassanye, A; Naudi, A; Lopez-Cano, C; Sanchez, E; de la Fuente-Juarez, MC; Herrerías González F; Olsina Kissler, JJ; Lecube, A; Portero-Otin, M
Adipose Tissue Protein Glycoxidation is Associated with Weight-Loss Potential
OBESITY 27 1133-1140. .
-
Servia, L; Jove, M; Sol, J; Pamplona, R; Badia, M; Montserrat, N; Portero-Otin, M; Trujillano, J
A prospective pilot study using metabolomics discloses specific fatty acid, catecholamine and tryptophan metabolic pathways as possible predictors for a negative outcome after severe trauma
SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE 27 56-56. .
-
Andres-Benito, P; Povedano, M; Torres, P; Portero-Otin, M; Ferrer, I
Altered Dynein Axonemal Assembly Factor 1 Expression in C-Boutons in Bulbar and Spinal Cord Motor-Neurons in Sporadic Amyotrophic Lateral Sclerosis
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 78 416-425. .
-
Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project
Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project
Journal of Atherosclerosis and Thrombosis 26 879-889. .
-
Granado-Serrano, AB; Martin-Gari, M; Sanchez, V; Riart Solans M; Berdun, R; Ludwig, IA; Rubio, L; Vilaprinyo, E; Portero-Otin, M; Serrano JCE
Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia
SCIENTIFIC REPORTS 9 1772-1772. .
-
Fernandez-Armenteros, JM; Gomez-Arbones, X; Buti-Soler, M; Betriu-Bars, A; Sanmartin-Novell, V; Ortega-Bravo, M; Martinez-Alonso, M; Gari, E; Portero-Otin, M; Santamaria-Babi, L; Casanova-Seuma, JM
Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 33 128-135. .
-
Montserrat-Capdevila, J; Seminario, MA; Godoy, P; Marsal, JR; Ortega, M; Pujol, J; Castan, MT; Alseda, M; Betriu À; Lecube, A; Portero, M; Purroy, F; Valdivielso, JM; Barbe, F
Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors
MEDICINA CLINICA 151 383-389. .
-
Moreno-Navarrete, JM; Liñares-Pose L; Sabater, M; Rial-Pensado, E; Comas, F; Jove, M; Latorre, J; Ortega, F; Ricart, W; Portero-Otin, M; Lopez, M; Fernandez-Real, JM
Adipose TSHB in Humans and Serum TSH in Hypothyroid Rats Inform About Cellular Senescence
Cellular Physiology And Biochemistry 51 142-153. .
-
Servia, L; Serrano JCE; Pamplona, R; Badia, M; Montserrat, N; Portero-Otin, M; Trujillano, J
Location-dependent effects of trauma on oxidative stress in humans
PLOS ONE 13 -. .
-
Dominguez-Gonzalez, M; Puigpinos, M; Jove, M; Naudi, A; Portero-Otin, M; Pamplona, R; Ferrer, I
Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging
Experimental Gerontology 111 218-228. .
-
Ranea-Robles, P; Launay, N; Ruiz, M; Calingasan, NY; Dumont, M; Naudi, A; Portero-Otin, M; Pamplona, R; Ferrer, I; Beal, MF; Fourcade, S; Pujol, A
Aberrant regulation of the GSK-3 beta/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
Embo Molecular Medicine 10 -. .
-
Cambray, S; Portero-Otin, M; Jove, M; Torreguitart, N; Colàs-Campàs L; Sanz, A; Benabdelhak, I; Yemisci, M; Dalkara, T; Dönmez-Demir B; Egea, J; Purroy, F
Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia
MOLECULAR NEUROBIOLOGY 55 6193-6200. .
Projectes
- Humanised mouse models to study ATG4B cryptic exon involvement in ALS pathogenesis and its potential as disease biomarker (Hum4ALS)
- Targeting cryptic exons as biomarkers and ALS therapy
- Desregulacion de TDP-43,eje clave en la ELA: Caracterización de firmas lipidómicas, transcriptómicas y autofágicas en muestras específicas de pacientes para biomarcadores y reposicionamiento
- The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis
- Perspectivas clínicas de la biología de sistemas aplicada al análisis de placas carotídeas humanas: ILER-CAROTID
- Metabolismo lipidico intracelular, procesamiento de ARNm y estrés celular en la encrucijada de la fisiopatología de la esclerosis lateral amiotrófica
- Identification of compounds for inhibition of ACE2 membrane expression
- Determinació de components bioactius derivats de la microbiota mitjançant micromostreig
- Reposicionamiento terapéutico dirigido a inhibición de expresión de ACE2 y de proteolisis de trímero S viral
- Estrés celulares y alteraciones en los lipidomas neuronales, gliales y extracelulares en la fisiopatología de la esclerosis lateral amiotrófica.
- "Imagenoma de l'Envelliment": Estudi observacional poblacional per definir biomarcadors d'imatge RM corporal integral i òmics que s'associen al procés d'envelliment i a factors de risc biopsicosocial en subjectes adults i que defineixen la seva trajectòria vital cap a un envelliment saludable o bé la fragilitat i discapacitat.
- Gut microbiota profile after consumption of a patented fiber formulation
